Itau Unibanco Holding S.A.’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-139	Closed	-$10K	–	646
2022 Q2	$10K	Buy	+139	New	+$6.18K	﹤0.01%	422

Itau Unibanco Holding S.A.'s TPTX Position: Q3 2022 in Review

Itau Unibanco Holding S.A. sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 139 shares — an estimated $10K sold.

Itau Unibanco Holding S.A. first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $10K in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Itau Unibanco Holding S.A. reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Itau Unibanco Holding S.A. sold 139 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $10K.
Itau Unibanco Holding S.A. first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Itau Unibanco Holding S.A.'s Turning Point Therapeutics, Inc. Common Stock position peaked at $10K in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q3 2022, filed 14 Nov 2022.